Repository logo
 
Publication

The European guidelines on diagnosis and management of neutropenia in adults and children: a consensus between the European Hematology Association and the EuNet-INNOCHRON COST Action

dc.contributor.authorFioredda, Francesca
dc.contributor.authorSkokowa, Julia
dc.contributor.authorTamary, Hannah
dc.contributor.authorSpanoudakis, Michail
dc.contributor.authorFarruggia, Piero
dc.contributor.authorAlmeida, António
dc.contributor.authorGuardo, Daniela
dc.contributor.authorHöglund, Petter
dc.contributor.authorNewburger, Peter E.
dc.contributor.authorPalmblad, Jan
dc.contributor.authorTouw, Ivo P.
dc.contributor.authorZeidler, Cornelia
dc.contributor.authorWarren, Alan J.
dc.contributor.authorDale, David C.
dc.contributor.authorWelte, Karl
dc.contributor.authorDufour, Carlo
dc.contributor.authorPapadaki, Helen A.
dc.date.accessioned2023-04-19T13:16:10Z
dc.date.available2023-04-19T13:16:10Z
dc.date.issued2023-04-30
dc.description.abstractNeutropenia, as an isolated blood cell deficiency, is a feature of a wide spectrum of acquired or congenital, benign or premalignant disorders with a predisposition to develop myelodysplastic neoplasms/acute myeloid leukemia that may arise at any age. In recent years, advances in diagnostic methodologies, particularly in the field of genomics, have revealed novel genes and mechanisms responsible for etiology and disease evolution and opened new perspectives for tailored treatment. Despite the research and diagnostic advances in the field, real world evidence, arising from international neutropenia patient registries and scientific networks, has shown that the diagnosis and management of neutropenic patients is mostly based on the physicians' experience and local practices. Therefore, experts participating in the European Network for the Innovative Diagnosis and Treatment of Chronic Neutropenias have collaborated under the auspices of the European Hematology Association to produce recommendations for the diagnosis and management of patients across the whole spectrum of chronic neutropenias. In the present article, we describe evidence-and consensus-based guidelines for the definition and classification, diagnosis, and follow-up of patients with chronic neutropenias including special entities such as pregnancy and the neonatal period. We particularly emphasize the importance of combining the clinical findings with classical and novel laboratory testing, and advanced germline and/or somatic mutational analyses, for the characterization, risk stratification, and monitoring of the entire spectrum of neutropenia patients. We believe that the wide clinical use of these practical recommendations will be particularly beneficial for patients, families, and treating physicians.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1097/HS9.0000000000000872pt_PT
dc.identifier.eid85151370312
dc.identifier.issn2572-9241
dc.identifier.pmcPMC10065839
dc.identifier.pmid37008163
dc.identifier.urihttp://hdl.handle.net/10400.14/40885
dc.identifier.wos000960625400001
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleThe European guidelines on diagnosis and management of neutropenia in adults and children: a consensus between the European Hematology Association and the EuNet-INNOCHRON COST Actionpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue4pt_PT
oaire.citation.titleHemaSpherept_PT
oaire.citation.volume7pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
67171503.pdf
Size:
891.53 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: